158 related articles for article (PubMed ID: 34620184)
21. Cost-effectiveness of preimplantation genetic testing for aneuploidies.
Somigliana E; Busnelli A; Paffoni A; Vigano P; Riccaboni A; Rubio C; Capalbo A
Fertil Steril; 2019 Jun; 111(6):1169-1176. PubMed ID: 30777289
[TBL] [Abstract][Full Text] [Related]
22. Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Kwon JS; Gutierrez-Barrera AM; Young D; Sun CC; Daniels MS; Lu KH; Arun B
J Clin Oncol; 2010 Sep; 28(27):4214-20. PubMed ID: 20733129
[TBL] [Abstract][Full Text] [Related]
23. Obstetric and Perinatal Outcomes in Pregnancies Conceived After Preimplantation Genetic Testing for Monogenetic Diseases.
Feldman B; Orvieto R; Weisel M; Aizer A; Meyer R; Haas J; Kirshenbaum M
Obstet Gynecol; 2020 Oct; 136(4):782-791. PubMed ID: 32925631
[TBL] [Abstract][Full Text] [Related]
24. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
[TBL] [Abstract][Full Text] [Related]
25. Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations.
Hallsson LR; Sroczynski G; Engel J; Siebert U
BMC Cancer; 2023 Jun; 23(1):590. PubMed ID: 37365514
[TBL] [Abstract][Full Text] [Related]
26. BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Kwon JS; Tinker AV; Hanley GE; Pansegrau G; Sun S; Carey MS; Schrader I
Gynecol Oncol; 2019 Mar; 152(3):459-464. PubMed ID: 30876489
[TBL] [Abstract][Full Text] [Related]
27. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
Nahshon C; Lavie O; Oron G
J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial.
He X; Wang X; Shen J; Wan B; Wang Y; Zhang Z; Cai L; Bao Y; Ding H; Li X
BMC Pregnancy Childbirth; 2023 Apr; 23(1):254. PubMed ID: 37060068
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
[TBL] [Abstract][Full Text] [Related]
30. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
[TBL] [Abstract][Full Text] [Related]
31. Impact of in vitro fertilization-preimplantation genetic testing (IVF-PGT) funding policy on clinical outcome: An issue that stems beyond effectiveness of treatment.
Shao YH; Zhang XY; Buckett W; Ao A
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():1-5. PubMed ID: 30743159
[TBL] [Abstract][Full Text] [Related]
32. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
Mor P; Brennenstuhl S; Metcalfe KA
J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles.
Lee M; Lofgren KT; Thomas A; Lanes A; Goldman R; Ginsburg ES; Hornstein MD
Am J Obstet Gynecol; 2021 Jul; 225(1):55.e1-55.e17. PubMed ID: 33539823
[TBL] [Abstract][Full Text] [Related]
34. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
[TBL] [Abstract][Full Text] [Related]
35. Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
Kwon JS; Daniels MS; Sun CC; Lu KH
J Clin Oncol; 2010 Feb; 28(4):675-82. PubMed ID: 19841329
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
Yamauchi H; Nakagawa C; Kobayashi M; Kobayashi Y; Mano T; Nakamura S; Arai M
Breast Cancer; 2018 Mar; 25(2):141-150. PubMed ID: 29019095
[TBL] [Abstract][Full Text] [Related]
37. The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool.
Goldman RH; Racowsky C; Farland LV; Fox JH; Munné S; Ribustello L; Ginsburg ES
J Assist Reprod Genet; 2018 Sep; 35(9):1641-1650. PubMed ID: 30066304
[TBL] [Abstract][Full Text] [Related]
38. Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.
Combs JC; Dougherty M; Yamasaki MU; DeCherney AH; Devine KM; Hill MJ; Rothwell E; O'Brien JE; Nelson RE
F S Rep; 2023 Sep; 4(3):300-307. PubMed ID: 37719105
[TBL] [Abstract][Full Text] [Related]
39. Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention.
Perri T; Farhadian Y; Friedman E; Korach J
Menopause; 2020 Jan; 27(1):82-87. PubMed ID: 31688415
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
